Inhibrx Biosciences vs Scinai Immunotherapeutics
INBX and SCNI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INBX and SCNI compare
Scinai Immunotherapeutics scores higher on the StockData Score (6 against 1 for Inhibrx Biosciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INBX | SCNI |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | – |
| Share price | $74.18 | $0.372 |
| Change, 1 year | −6.3% | −96.2% |
| Change, 5 years | 93.5% | −100.0% |
| Beta (5Y) | 2.16 | 1.20 |
| Employees | 110 | 45 |
| StockData Score | ||
| Total score | 1 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| FCF yield | −12.2% | – |
| Growth | ||
| Revenue growth (TTM) | – | 99.2% |
| Revenue growth, 5Y average | −36.8% | – |
| Net income growth (TTM) | – | −273% |
| Profitability | ||
| Gross margin | – | −202% |
| Operating margin | – | −575% |
| Net margin | – | −634% |
| FCF margin | – | −462% |
| Return on equity | – | −84.8% |
| Return on invested capital | – | −74.7% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −5.9× | – |
| Current ratio | 7.58 (better) | 1.56 |
| Altman Z-score | −1.02 | – |
| Piotroski F-score | 1 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 97.4% | – |
| Held by insiders | 35.4% | 7.4% |
| Insider net buying, 12 months | $6.1M | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 35.7% | – |
Go deeper
- INBX stock overview
- INBX income statement
- INBX valuation and score
- SCNI stock overview
- SCNI income statement
- SCNI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.